P09467 (F16P1_HUMAN) Homo sapiens (Human)

Fructose-1,6-bisphosphatase 1 UniProtKBInterProSTRINGInteractive Modelling

338 aa; Sequence (Fasta)

Available Structures

49 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Quadruple space group ambiguity due to rotational and translational non-crystallographic symmetry i…homo-4-mer6-337
ZN; 20×SO4;CL;
Assess
Human Fructose-1,6-bisphosphatase 1 in APO R-statehomo-4-mer8-337
MG;
Assess
Human Fructose-1,6-bisphosphatase 1 mutant R50A in APO R-statehomo-4-mer8-336
Assess
Indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatasehomo-4-mer9-337
0KI;FBP;
Assess
Indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatasehomo-4-mer9-337
FBP;0GI;
Assess
Indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatasehomo-4-mer9-337
0H1;FBP;
Assess
FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE -1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLE…homo-4-mer10-337
R15;
Assess
Orally active aminopyridines as inhibitors of tetrameric fructose 1,6- bisphosphatasehomo-4-mer10-337
YCU;
Assess
FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE -1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLE…homo-4-mer10-337
ROK;
Assess
orally active aminopyridines as inhibitors of tetrameric fructose 1,6- bisphosphatasehomo-4-mer10-337
RO8;
Assess
FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEX…homo-4-mer10-337
RO3;
Assess
The N-arylsulfonyl-indole-2-carboxamide-based inhibitors against fructose-1,6-bisphosphatasehomo-4-mer10-337
EW0;
Assess
FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEX…homo-4-mer10-337
RO5;
Assess
The N-arylsulfonyl-indole-2-carboxamide-based inhibitors against fructose-1,6-bisphosphatasehomo-4-mer10-337
GJO;FBP;
Assess
Structure of human liver FBPase complexed with potent benzoxazole allosteric inhibitorshomo-4-mer10-337
A74;
Assess
Structure of human liver FBPase complexed with potent benzoxazole allosteric inhibitiorshomo-4-mer10-337
870;
Assess
Crystal structure of human liver FBPase complexed with an covalent inhibitorhomo-4-mer10-336
AMP;LSA;MG;PMQ;GOL;
Assess
Crystal structure of Human liver fructose-1,6-bisphoaphatase complex with Mg2+ and AMPhomo-4-mer10-336
AMP;MG;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
96A;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
93S;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
94D;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
94G;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
94J;AMZ;
Assess
Structure of human liver FBPase complexed with covalent allosteric inhibitorhomo-4-mer10-336
EUF;AMP;MG;
Assess
Human Fructose-1,6-bisphosphatase 1 in complex with geranylgeranyl diphosphatehomo-4-mer10-336
FBP;MG;AMP;GRG;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
95J;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
967;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
95S;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
94V;
Assess
Crystal structure of human liver FBPase in complex with tricyclic inhibitor 19ahomo-4-mer10-336
2T6;
Assess
FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE, 1-PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEX…homo-4-mer10-336
AMP;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
96D;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
96J;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
95M;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
93Y;
Assess
Human liver fructose-1,6-bisphosphatase(d-fructose-1,6-bisphosphate, 1-phosphohydrolase) (e.c.3.1.3…homo-4-mer10-336
2C1;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
95V;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
95Y;
Assess
Crystal structure of human liver FBPase in complex with tricyclic inhibitor 6homo-4-mer10-336
2T4;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
94Y;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
95P;
Assess
Crystal structure of human liver FBPase in complex with tricyclic inhibitorhomo-4-mer10-336
2T0;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
95D;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
95G;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
93V;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
94S;
Assess
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) c…homo-4-mer10-336
947;
Assess
Crystal structure of human liver FBPase in complex with tricyclic inhibitor 10bhomo-4-mer10-336
2T5;
Assess
Structure of human liver FPBase complexed with a novel benzoxazole as allosteric inhibitorhomo-4-mer10-336
MG;A37;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2f3d.1.Dhomo-4-mer0.8711-338
F6P; 12×ZN;89.94
Assess